Analystreport

Meridian Bioscience, Inc. (NASDAQ: VIVO) had its price target raised by analysts at HC Wainwright from $28.00 to $30.00.

Meridian Bioscience Inc.  (VIVO) 
Last meridian bioscience inc. earnings: 2/7 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investor.meridianbioscience.com